Literature DB >> 6717852

Reduced binding of [3H]ketanserin to cortical 5-ht2 receptors in senile dementia of the Alzheimer type.

G P Reynolds, L Arnold, M N Rossor, L L Iversen, C Q Mountjoy, M Roth.   

Abstract

Using [3H]ketanserin, a specific ligand for the 5-HT2 receptor, the amount of specific binding was measured in preparations of post-mortem frontal cortex from subjects diagnosed as suffering from dementia. A highly significant 42% loss of binding was observed which reflected a decrease in receptor density compared to psychiatrically normal controls. This was found to be independent of age in the demented patients and thus unlikely to be related to the cholinergic deficit. Measurement of 5-HT and its metabolite 5-HIAA indicated a smaller, non-significant decrease in presynaptic 5-HT function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6717852     DOI: 10.1016/0304-3940(84)90219-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms.

Authors:  A W Procter; P T Francis; G C Stratmann; D M Bowen
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 2.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

3.  Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain.

Authors:  A C Andorn; M A Pappolla; H Fox; F K Klemens; P A Martello
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.

Authors:  D T Chalmers; D Dewar; D I Graham; D N Brooks; J McCulloch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 5.  A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders.

Authors:  E Salmon
Journal:  J Neural Transm (Vienna)       Date:  2007-02-19       Impact factor: 3.575

6.  Nucleus raphe dorsalis in parkinsonism-dementia complex of Guam.

Authors:  T Yamamoto; A Hirano
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.

Authors:  C C Smith; D M Bowen; P T Francis; J S Snowden; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-05       Impact factor: 10.154

Review 8.  Monoamine neurons in aging and Alzheimer's disease.

Authors:  A M Palmer; S T DeKosky
Journal:  J Neural Transm Gen Sect       Date:  1993

9.  Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.

Authors:  A J Nazarali; G P Reynolds
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

10.  Age-related behavioural, neurochemical and radioligand binding changes in the central 5-HT system of Sprague-Dawley rats.

Authors:  L Robson; A J Gower; D A Kendall; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.